Pitcairn’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-10,892
| Closed | -$286K | – | 631 |
|
2022
Q1 | $286K | Sell |
10,892
-55
| -0.5% | -$1.44K | 0.02% | 514 |
|
2021
Q4 | $260K | Buy |
10,947
+913
| +9% | +$21.7K | 0.02% | 559 |
|
2021
Q3 | $252K | Buy |
10,034
+319
| +3% | +$8.01K | 0.02% | 555 |
|
2021
Q2 | $253K | Buy |
+9,715
| New | +$253K | 0.02% | 543 |
|
2018
Q4 | – | Sell |
-8,803
| Closed | -$314K | – | 548 |
|
2018
Q3 | $314K | Sell |
8,803
-513
| -6% | -$18.3K | 0.03% | 394 |
|
2018
Q2 | $322K | Sell |
9,316
-487
| -5% | -$16.8K | 0.03% | 376 |
|
2018
Q1 | $330K | Sell |
9,803
-3,201
| -25% | -$108K | 0.04% | 348 |
|
2017
Q4 | $497K | Buy |
13,004
+110
| +0.9% | +$4.2K | 0.05% | 266 |
|
2017
Q3 | $484K | Sell |
12,894
-647
| -5% | -$24.3K | 0.05% | 255 |
|
2017
Q2 | $505K | Buy |
13,541
+2,845
| +27% | +$106K | 0.06% | 234 |
|
2017
Q1 | $419K | Sell |
10,696
-372
| -3% | -$14.6K | 0.05% | 281 |
|
2016
Q4 | $385K | Buy |
11,068
+2,867
| +35% | +$99.7K | 0.05% | 318 |
|
2016
Q3 | $323K | Sell |
8,201
-102
| -1% | -$4.02K | 0.04% | 350 |
|
2016
Q2 | $314K | Sell |
8,303
-28
| -0.3% | -$1.06K | 0.04% | 330 |
|
2016
Q1 | $320K | Buy |
8,331
+1,177
| +16% | +$45.2K | 0.04% | 326 |
|
2015
Q4 | $344K | Sell |
7,154
-899
| -11% | -$43.2K | 0.04% | 308 |
|
2015
Q3 | $318K | Sell |
8,053
-1,233
| -13% | -$48.7K | 0.04% | 313 |
|
2015
Q2 | $395K | Sell |
9,286
-14,169
| -60% | -$603K | 0.05% | 305 |
|
2015
Q1 | $926K | Sell |
23,455
-1,745
| -7% | -$68.9K | 0.1% | 165 |
|
2014
Q4 | $909K | Sell |
25,200
-5,939
| -19% | -$214K | 0.1% | 162 |
|
2014
Q3 | $919K | Buy |
31,139
+731
| +2% | +$21.6K | 0.1% | 158 |
|
2014
Q2 | $765K | Sell |
30,408
-521
| -2% | -$13.1K | 0.08% | 187 |
|
2014
Q1 | $798K | Buy |
30,929
+1,024
| +3% | +$26.4K | 0.09% | 180 |
|
2013
Q4 | $673K | Buy |
29,905
+1,923
| +7% | +$43.3K | 0.07% | 201 |
|
2013
Q3 | $396K | Buy |
+27,982
| New | +$396K | 0.05% | 288 |
|